International Stem Cell CORP (ISCO) › Shares OutstandingInternational Stem Cell CORP (ISCO) — Shares OutstandingAnnual figures by period end, from SEC filings.2010-12-31: 74.77M2011-12-31: 80.04M2012-12-31: 87.39M2013-12-31: 151.18M2014-12-31: 1.60M2015-12-31: 2.81M2016-12-31: 3.95M2017-12-31: 6.06M2018-12-31: 6.93M2019-12-31: 7.54M2020-12-31: 7.54M2021-12-31: 8.00M2022-12-31: 8.00M2023-12-31: 8.00M2024-12-31: 8.00M2025-12-31: 8.00M8.00M2010-12-31Shares Outstanding (shares)2025-12-31Period endedShares OutstandingChange YoYSource filing2025-12-318.00M+0.0%2026-03-30Balance as of period end2024-12-318.00M+0.0%2026-03-30Balance as of period end2023-12-318.00M+0.0%2025-03-28Balance as of period end2022-12-318.00M+0.0%2024-03-28Balance as of period end2021-12-318.00M+6.2%2023-03-30Balance as of period end2020-12-317.54M+0.0%2022-03-29Balance as of period end2019-12-317.54M+8.7%2021-03-30Balance as of period end2018-12-316.93M+14.5%2020-06-01Balance as of period end2017-12-316.06M+53.3%2019-04-15Balance as of period end2016-12-313.95M+40.7%2018-04-09Balance as of period end2015-12-312.81M+76.0%2017-03-31Balance as of period end2014-12-311.60M-98.9%2016-03-30Balance as of period end2013-12-31151.18M+73.0%2015-03-30Balance as of period end2012-12-3187.39M+9.2%2014-03-17Balance as of period end2011-12-3180.04M+7.0%2013-03-26Balance as of period end2010-12-3174.77M—2012-03-16Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per ShareWeighted Average Diluted SharesEPS (Basic)